Drug reference
favipiravir
Investigational Antiviral agent (RNA polymerase inhibitor)
Investigational Antiviral agent (RNA polymerase inhibitor)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Favipiravir (T705) inhibits viral RNA polymerases.
Drug interactions
12 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Related guidelines
Other Unclassified drugs
Ask House about favipiravir
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Harrison 22e·Updated: 2026-05-10